Eur Radiol:前列腺癌根治术时如何评价切缘是否有浸润?

2021-04-25 shaosai MedSci原创

根治性前列腺切除术后阳性手术切缘的存在会大大增加患者肿瘤复发的风险。尽管达到切缘阴性仍然是RP的主要目标,但保留神经血管束和膜性尿道功能也同样重要。

    根治性前列腺切除术(RP)后阳性手术切缘(PSMs)的存在会大大增加患者肿瘤复发的风险。PSM的存在与术前前列腺特异性抗原(PSA)水平高、肿瘤位于前列腺尖部或后外侧、前列腺体积以及骨盆解剖有关,同时外科医生的经验和手术类型的选择也会影响PSM的发生率。然而,尽管达到切缘阴性仍然是RP的主要目标,但保留神经血管束和膜性尿道功能也同样重要。为了优化术后器官功能和肿瘤预后,个性化治疗方法的制定显得尤为重要。

    由于MRI (mpMRI)成像可同时提供骨盆解剖、前列腺体积、肿瘤位置等信息,可以全面评估增加PSMs风险的解剖困难和不良肿瘤特征,已被临床广泛用于RP术前的常规影像学检查手段。近日,发表在European Radiology杂志的一项研究建立并验证了一个基于MRI的简单模型来前列腺癌(PCa)患者接受根治性前列腺切除术(RP)后出现阳性手术切缘(PSMs)的风险,该模型可以用于临床进行术前个性化治疗方案的制定。

    本研究回顾性评价了从三级转诊医院接受RP治疗的连续的前列腺癌患者。2014年1月至2014年6月期间行RP的患者被分配为推导队列(n = 330), 2018年1月至2018年2月期间的患者被分配为验证队列(n = 100)。评估了基于MRI的PSM相关预测因素:肿瘤大小、肿瘤-包膜接触长度、前列腺成像报告和数据系统(PI-RADS)类别、肿瘤位置(肿瘤接位于尖部或靠近神经血管束的后外侧)、尖部深度和前列腺体积。采用多变量逻辑回归建立预测模型,并将其转化为评分系统。采用C统计和Hosmer-Lemeshow拟合优度检验评价该评分系统的预测和校准性能。

    在推导和验证队列中,共有121(36.7%)和32(32.0%)患者在RP后出现PSM。评分系统包括以下变量:肿瘤-包膜接触长度、PI-RADS类别、肿瘤位于尖部和/或后外侧。该评分系统在推导(C statistics, 0.80 [95% CI: 0.76, 0.85])和验证(C statistics, 0.77 [95% CI: 0.68, 0.87])队列中提供了良好的预测PSM的性能,并在两个队列中显示了良好的校准性能(p分别为0.83和0.86)。

图1 前列腺尖部深度、肿瘤-包膜接触长度的测量、肿瘤位于尖部和后外侧的示例。(a)在矢状位T2WI图像上,前列腺尖部深度(箭头)定义为从耻骨联合近端边缘(虚线)到前列腺尖端远端边缘。(b)肿瘤-包膜接触长度(曲线)定义为肿瘤与前列腺包膜接触的曲线长度。如果肿瘤(箭头)显示在前列腺尖部(c,距前列腺尖部远端3mm以内)或后外侧靠近神经血管束(d,星号),则认为肿瘤尖部(c)或后外侧(d)接触为“阳性”。

表1 使用多变量logistic回归模型,基于MRI的前列腺癌切除术后切缘阳性的预测因子 。

图2 评分系统、肿瘤-包膜接触长度、PI-RADS分类以及国际泌尿外科病理学会对所有患者手术切缘阳性预测分级的ROC曲线。与肿瘤-包膜接触长度 (AUC, 0.74;95%置信区间:0.70-0.78;p < 0.001)、 PI-RADS分类(AUC, 0.72;95%置信区间:0.67-0.76;p < 0.001)、 Gleason评分(AUC, 0.70;95%置信区间:0.66-0.74;p < 0.001)相比,评分系统的AUC明显较高(AUC, 0.80;95%置信区间:0.76-0.83)。

    本研究提出了一个预测和校准能力均较强的基于MRI的预测RP后PSM风险的评分系统,该评分系统可协助临床医生术前准确评估切缘阳性的风险,从而确保了最佳手术方案的制定。

原始出处:

Mi Yeon Park,Kye Jin Park,Mi-Hyun Kim,et al. Preoperative MRI-based estimation of risk for positive resection margin after radical prostatectomy in patients with prostate cancer: development and validation of a simple scoring system.DOI:10.1007/s00330-020-07569-z

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1986567, encodeId=2067198656e3b, content=<a href='/topic/show?id=5822325417e' target=_blank style='color:#2F92EE;'>#前列腺癌根治术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32541, encryptionId=5822325417e, topicName=前列腺癌根治术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=bugit, createdTime=Sat Jan 01 12:11:34 CST 2022, time=2022-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1399751, encodeId=05441399e519e, content=<a href='/topic/show?id=72406223398' target=_blank style='color:#2F92EE;'>#根治术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62233, encryptionId=72406223398, topicName=根治术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=03a52234941, createdName=bluefate122, createdTime=Tue Apr 27 02:11:34 CST 2021, time=2021-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1444692, encodeId=02411444692d7, content=<a href='/topic/show?id=3d9291459d1' target=_blank style='color:#2F92EE;'>#评价#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91459, encryptionId=3d9291459d1, topicName=评价)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1fee5134542, createdName=huagfeg, createdTime=Tue Apr 27 02:11:34 CST 2021, time=2021-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1586218, encodeId=0e46158621890, content=<a href='/topic/show?id=38f8622191b' target=_blank style='color:#2F92EE;'>#根治#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62219, encryptionId=38f8622191b, topicName=根治)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26d917348678, createdName=jeanqiuqiu, createdTime=Tue Apr 27 02:11:34 CST 2021, time=2021-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=960707, encodeId=8a22960e0740, content=已读,真是受益匪浅呀!, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f03a5433387, createdName=ms5000000518166734, createdTime=Mon Apr 26 19:34:24 CST 2021, time=2021-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1041001, encodeId=9f861041001bf, content=前列腺癌相关研究,学习了,谢谢梅斯, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=misszhang, createdTime=Sun Apr 25 14:11:34 CST 2021, time=2021-04-25, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1986567, encodeId=2067198656e3b, content=<a href='/topic/show?id=5822325417e' target=_blank style='color:#2F92EE;'>#前列腺癌根治术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32541, encryptionId=5822325417e, topicName=前列腺癌根治术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=bugit, createdTime=Sat Jan 01 12:11:34 CST 2022, time=2022-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1399751, encodeId=05441399e519e, content=<a href='/topic/show?id=72406223398' target=_blank style='color:#2F92EE;'>#根治术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62233, encryptionId=72406223398, topicName=根治术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=03a52234941, createdName=bluefate122, createdTime=Tue Apr 27 02:11:34 CST 2021, time=2021-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1444692, encodeId=02411444692d7, content=<a href='/topic/show?id=3d9291459d1' target=_blank style='color:#2F92EE;'>#评价#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91459, encryptionId=3d9291459d1, topicName=评价)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1fee5134542, createdName=huagfeg, createdTime=Tue Apr 27 02:11:34 CST 2021, time=2021-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1586218, encodeId=0e46158621890, content=<a href='/topic/show?id=38f8622191b' target=_blank style='color:#2F92EE;'>#根治#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62219, encryptionId=38f8622191b, topicName=根治)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26d917348678, createdName=jeanqiuqiu, createdTime=Tue Apr 27 02:11:34 CST 2021, time=2021-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=960707, encodeId=8a22960e0740, content=已读,真是受益匪浅呀!, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f03a5433387, createdName=ms5000000518166734, createdTime=Mon Apr 26 19:34:24 CST 2021, time=2021-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1041001, encodeId=9f861041001bf, content=前列腺癌相关研究,学习了,谢谢梅斯, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=misszhang, createdTime=Sun Apr 25 14:11:34 CST 2021, time=2021-04-25, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1986567, encodeId=2067198656e3b, content=<a href='/topic/show?id=5822325417e' target=_blank style='color:#2F92EE;'>#前列腺癌根治术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32541, encryptionId=5822325417e, topicName=前列腺癌根治术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=bugit, createdTime=Sat Jan 01 12:11:34 CST 2022, time=2022-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1399751, encodeId=05441399e519e, content=<a href='/topic/show?id=72406223398' target=_blank style='color:#2F92EE;'>#根治术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62233, encryptionId=72406223398, topicName=根治术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=03a52234941, createdName=bluefate122, createdTime=Tue Apr 27 02:11:34 CST 2021, time=2021-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1444692, encodeId=02411444692d7, content=<a href='/topic/show?id=3d9291459d1' target=_blank style='color:#2F92EE;'>#评价#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91459, encryptionId=3d9291459d1, topicName=评价)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1fee5134542, createdName=huagfeg, createdTime=Tue Apr 27 02:11:34 CST 2021, time=2021-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1586218, encodeId=0e46158621890, content=<a href='/topic/show?id=38f8622191b' target=_blank style='color:#2F92EE;'>#根治#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62219, encryptionId=38f8622191b, topicName=根治)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26d917348678, createdName=jeanqiuqiu, createdTime=Tue Apr 27 02:11:34 CST 2021, time=2021-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=960707, encodeId=8a22960e0740, content=已读,真是受益匪浅呀!, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f03a5433387, createdName=ms5000000518166734, createdTime=Mon Apr 26 19:34:24 CST 2021, time=2021-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1041001, encodeId=9f861041001bf, content=前列腺癌相关研究,学习了,谢谢梅斯, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=misszhang, createdTime=Sun Apr 25 14:11:34 CST 2021, time=2021-04-25, status=1, ipAttribution=)]
    2021-04-27 huagfeg
  4. [GetPortalCommentsPageByObjectIdResponse(id=1986567, encodeId=2067198656e3b, content=<a href='/topic/show?id=5822325417e' target=_blank style='color:#2F92EE;'>#前列腺癌根治术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32541, encryptionId=5822325417e, topicName=前列腺癌根治术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=bugit, createdTime=Sat Jan 01 12:11:34 CST 2022, time=2022-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1399751, encodeId=05441399e519e, content=<a href='/topic/show?id=72406223398' target=_blank style='color:#2F92EE;'>#根治术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62233, encryptionId=72406223398, topicName=根治术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=03a52234941, createdName=bluefate122, createdTime=Tue Apr 27 02:11:34 CST 2021, time=2021-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1444692, encodeId=02411444692d7, content=<a href='/topic/show?id=3d9291459d1' target=_blank style='color:#2F92EE;'>#评价#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91459, encryptionId=3d9291459d1, topicName=评价)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1fee5134542, createdName=huagfeg, createdTime=Tue Apr 27 02:11:34 CST 2021, time=2021-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1586218, encodeId=0e46158621890, content=<a href='/topic/show?id=38f8622191b' target=_blank style='color:#2F92EE;'>#根治#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62219, encryptionId=38f8622191b, topicName=根治)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26d917348678, createdName=jeanqiuqiu, createdTime=Tue Apr 27 02:11:34 CST 2021, time=2021-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=960707, encodeId=8a22960e0740, content=已读,真是受益匪浅呀!, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f03a5433387, createdName=ms5000000518166734, createdTime=Mon Apr 26 19:34:24 CST 2021, time=2021-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1041001, encodeId=9f861041001bf, content=前列腺癌相关研究,学习了,谢谢梅斯, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=misszhang, createdTime=Sun Apr 25 14:11:34 CST 2021, time=2021-04-25, status=1, ipAttribution=)]
    2021-04-27 jeanqiuqiu
  5. [GetPortalCommentsPageByObjectIdResponse(id=1986567, encodeId=2067198656e3b, content=<a href='/topic/show?id=5822325417e' target=_blank style='color:#2F92EE;'>#前列腺癌根治术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32541, encryptionId=5822325417e, topicName=前列腺癌根治术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=bugit, createdTime=Sat Jan 01 12:11:34 CST 2022, time=2022-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1399751, encodeId=05441399e519e, content=<a href='/topic/show?id=72406223398' target=_blank style='color:#2F92EE;'>#根治术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62233, encryptionId=72406223398, topicName=根治术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=03a52234941, createdName=bluefate122, createdTime=Tue Apr 27 02:11:34 CST 2021, time=2021-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1444692, encodeId=02411444692d7, content=<a href='/topic/show?id=3d9291459d1' target=_blank style='color:#2F92EE;'>#评价#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91459, encryptionId=3d9291459d1, topicName=评价)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1fee5134542, createdName=huagfeg, createdTime=Tue Apr 27 02:11:34 CST 2021, time=2021-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1586218, encodeId=0e46158621890, content=<a href='/topic/show?id=38f8622191b' target=_blank style='color:#2F92EE;'>#根治#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62219, encryptionId=38f8622191b, topicName=根治)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26d917348678, createdName=jeanqiuqiu, createdTime=Tue Apr 27 02:11:34 CST 2021, time=2021-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=960707, encodeId=8a22960e0740, content=已读,真是受益匪浅呀!, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f03a5433387, createdName=ms5000000518166734, createdTime=Mon Apr 26 19:34:24 CST 2021, time=2021-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1041001, encodeId=9f861041001bf, content=前列腺癌相关研究,学习了,谢谢梅斯, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=misszhang, createdTime=Sun Apr 25 14:11:34 CST 2021, time=2021-04-25, status=1, ipAttribution=)]
    2021-04-26 ms5000000518166734

    已读,真是受益匪浅呀!

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1986567, encodeId=2067198656e3b, content=<a href='/topic/show?id=5822325417e' target=_blank style='color:#2F92EE;'>#前列腺癌根治术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32541, encryptionId=5822325417e, topicName=前列腺癌根治术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=bugit, createdTime=Sat Jan 01 12:11:34 CST 2022, time=2022-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1399751, encodeId=05441399e519e, content=<a href='/topic/show?id=72406223398' target=_blank style='color:#2F92EE;'>#根治术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62233, encryptionId=72406223398, topicName=根治术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=03a52234941, createdName=bluefate122, createdTime=Tue Apr 27 02:11:34 CST 2021, time=2021-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1444692, encodeId=02411444692d7, content=<a href='/topic/show?id=3d9291459d1' target=_blank style='color:#2F92EE;'>#评价#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91459, encryptionId=3d9291459d1, topicName=评价)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1fee5134542, createdName=huagfeg, createdTime=Tue Apr 27 02:11:34 CST 2021, time=2021-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1586218, encodeId=0e46158621890, content=<a href='/topic/show?id=38f8622191b' target=_blank style='color:#2F92EE;'>#根治#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62219, encryptionId=38f8622191b, topicName=根治)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26d917348678, createdName=jeanqiuqiu, createdTime=Tue Apr 27 02:11:34 CST 2021, time=2021-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=960707, encodeId=8a22960e0740, content=已读,真是受益匪浅呀!, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f03a5433387, createdName=ms5000000518166734, createdTime=Mon Apr 26 19:34:24 CST 2021, time=2021-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1041001, encodeId=9f861041001bf, content=前列腺癌相关研究,学习了,谢谢梅斯, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=misszhang, createdTime=Sun Apr 25 14:11:34 CST 2021, time=2021-04-25, status=1, ipAttribution=)]
    2021-04-25 misszhang

    前列腺癌相关研究,学习了,谢谢梅斯

    0

相关资讯

Eur Radiol:CTA对前列腺动脉栓塞术的价值

前列腺动脉栓塞术是一个技术上相对困难的手术。然而到目前为止,对影响PAE技术困难度因素的研究十分有限,且迄今为止大多数的相关研究均对患者变量使用主观测量。

Prostate:抑制STAT3可防止体内前列腺癌的骨转移

前列腺癌(PC)转移到骨骼会形成以硬化为主的病变,目前对骨转移性疾病还没有治愈的办法。转录因子信号转导和转录激活因子3(STAT3)认为是转移的驱动因素,但它作为骨转移的治疗靶点的潜力还没有研究。

Prostate Cancer P D:新诊断转移性前列腺癌放射治疗的长期结果

在转移性前列腺癌患者中,局部治疗的作用在不断发展。近期报道的两项大规模随机试验表明,针对前列腺的放疗可提高低转移负荷患者的总生存(OS)。

Eur Urol Focus:前列腺活检与前列腺钬激光剜除术之间的短时间间隔与较差的围手术期结果有关

目前还没有关于经直肠前列腺活检(PB)和前列腺钬激光切除术(HoLEP)之间的时间间隔对围手术期结果影响的数据。

Br J Cancer:尿液中雌激素水平可作为前列腺癌发生发展的风险指标

前列腺癌(PCa)作为全球男性中第二常见的癌症,在2018年有120万以上的确诊病例,死亡人数超过350,000。

Prostate Cancer P D:恩杂鲁胺或阿比特龙治疗转移去势抵抗性前列腺癌男性的生活质量

恩杂鲁胺与醋酸阿比特龙加泼尼松(AAP)对转移去势抵抗性前列腺癌(mCRPC)的疗效相似,但作用机制不同。